astragaloside a has been researched along with Diabetic Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Dong, X; Kuang, B; Li, B; Li, X; Li, Z; Wu, Y; Zhang, L | 1 |
| Wang, H; Wang, J; Zhang, H; Zhang, Z; Zhu, Y | 1 |
| Ji, T; Li, W; Wang, Z; Zhang, J; Zhang, Y; Zhu, Y | 1 |
3 other study(ies) available for astragaloside a and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis.
Topics: Animals; CD36 Antigens; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Down-Regulation; Ferroptosis; Lipids; Myocytes, Cardiac; Rats | 2023 |
Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Male; Muscle Proteins; Myocardium; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2019 |
Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diet, High-Fat; Fibrosis; Inflammation; Lipid Metabolism; Male; Myocardium; Rats; Saponins; Triterpenes | 2020 |